ALINITY I ANTI-HCV REAGENT KIT
Report
- Report Number
- 3002809144-2026-00111
- Event Type
- Malfunction
- Date Received
- April 30, 2026
- Date of Event
- April 20, 2026
- Report Date
- April 30, 2026
- Manufacturer
- ABBOTT GMBH
- Product Code
- MZO
- UDI-DI
- 00380740162665
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CH
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, LIST NUMBER 08P06-74 THAT HAS A SIMILAR PRODUCT DISTRIBUTED IN THE US, LIST NUMBER 8P05, WITH 510K/PMA/BLA NUMBER P050042. AN EVALUATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE. SECTION A PATIENT INFORMATION: REFER TO SECTION B5 FOR COMPLETE PATIENT INFORMATION.
THE CUSTOMER REPORTED FALSE NONREACTIVE ALINITY I ANTI-HCV RESULTS GENERATED ON THE ALINITY I PROCESSING MODULE. THE FOLLOWING DATA WAS PROVIDED: SAMPLE 1: SID (B)(6), (31-YEAR-OLD, MALE): ALINITY I ANTI-HCV = 0.16 / 0.17 S/CO (NONREACTIVE) WANTAI PLATFORM = 2.36 AND 2.71 S/CO AFTER HIGH-SPEED CENTRIFUGATION (POSITIVE) ROCHE CHEMILUMINESCENCE PLATFORM = 5.17 COI (POSITIVE) . ADDITIONAL TESTING PROVIDED: HCV AG RESULT = 0.00 FMOL/L RESULTS OF THE HEPATITIS B FIVE-ASSAY PANEL RESULTS: ANTI-HBS, ANTI-HBE, AND ANTI-HBC GENERATED POSITIVE RESULTS; HBSAG AND HBEAG GENERATED NEGATIVE RESULTS. THE PATIENT HAS A HISTORY OF POOR APPETITE, HELICOBACTER PYLORI INFECTION, AND ABNORMAL LIVER FUNCTION TESTS. THERE WAS NO IMPACT TO PATIENT MANAGEMENT REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 262759 | ALINITY I ANTI-HCV REAGENT KIT | ASSAY, ENZYME LINKED IMMUNOSORBENT, HEPATITIS C VIRUS | MZO | ABBOTT GMBH | 81196BE01 | 00380740162665 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 31 YR | Male | ALNTY I PROCESSING MODU, 03R65-01, (B)(6) |